ClinicalTrials.Veeva

Menu
V

Victorium Clinical Research | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Sugar
Metformin
NNC0487-0111
TAK-279
Icotrokinra
Empagliflozin
Elismetrep
K-304
Verekitug
Finerenone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 17 total trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Enrolling
Acute Migraine
Drug: Elismetrep

The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and ado...

Active, not recruiting
Colitis, Ulcerative
Drug: Icotrokinra
Drug: Placebo
New

The study is testing zenagamtide in participants with type 2 diabetes. The purpose of this clinical study is to find out if zenagamtide is safe and e...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Placebo semaglutide
Drug: Semaglutide
New

The study is testing zenagamtide in participants with type 2 diabetes and chronic kidney disease. The purpose of this clinical study is to find out i...

Not yet enrolling
Chronic Kidney Disease
Type 2 Diabetes
Other: Placebo
Drug: Zenagamtide

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or He...

Enrolling
Obesity
Heart Failure
Drug: NNC0487-0111
Drug: Placebo

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately t...

Enrolling
Crohn Disease
Drug: Icotrokinra
Drug: Placebo

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate t...

Enrolling
Crohn's Disease
Drug: Placebo
Drug: TAK-279

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical...

Active, not recruiting
Ulcerative Colitis
Drug: TAK-279
Drug: Placebo

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Other: Placebo
Drug: Verekitug

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep
New

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have type 2 diabetes. There are 2 stud...

Not yet enrolling
Type 2 Diabetes
Drug: Zenagamtide
Drug: Placebo
Locations recently updated

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Trial sponsors

Novo Nordisk logo
Janssen (J&J Innovative Medicine) logo
Takeda logo
T
Bayer logo
Boehringer Ingelheim logo
Mylan logo
Pfizer logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems